OBLN

Obalon Therapeutics (OBLN)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OBLN
DataOraFonteTitoloSimboloCompagnia
16/05/202312:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OBLNObalon Therapeutics Inc
15/05/202323:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OBLNObalon Therapeutics Inc
24/04/202315:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OBLNObalon Therapeutics Inc
03/04/202323:12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:OBLNObalon Therapeutics Inc
17/03/202322:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OBLNObalon Therapeutics Inc
14/02/202319:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OBLNObalon Therapeutics Inc
08/02/202315:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202315:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202312:05Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:OBLNObalon Therapeutics Inc
12/01/202323:10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:OBLNObalon Therapeutics Inc
20/12/202222:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OBLNObalon Therapeutics Inc
10/11/202222:56Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OBLNObalon Therapeutics Inc
31/10/202221:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OBLNObalon Therapeutics Inc
26/08/202222:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OBLNObalon Therapeutics Inc
16/08/202212:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:OBLNObalon Therapeutics Inc
22/03/202211:04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OBLNObalon Therapeutics Inc
21/09/202122:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OBLNObalon Therapeutics Inc
03/09/202122:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OBLNObalon Therapeutics Inc
21/05/202115:00Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OBLNObalon Therapeutics Inc
12/05/202114:40GlobeNewswire Inc.Obalon Announces First Quarter 2021 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
09/04/202123:22Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OBLNObalon Therapeutics Inc
30/03/202112:11Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OBLNObalon Therapeutics Inc
15/03/202115:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OBLNObalon Therapeutics Inc
13/03/202101:12GlobeNewswire Inc.Obalon Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
03/02/202123:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OBLNObalon Therapeutics Inc
06/11/202022:45GlobeNewswire Inc.Obalon Announces Third Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
25/09/202022:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OBLNObalon Therapeutics Inc
01/09/202022:55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OBLNObalon Therapeutics Inc
13/08/202013:00GlobeNewswire Inc.Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon SystemNASDAQ:OBLNObalon Therapeutics Inc
30/07/202012:38GlobeNewswire Inc.Obalon Announces Second Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OBLN
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network